newsfilter
← Latest News
PR Newswire·

YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024

YS

YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...